Bullfrog AI (BFRG) vs Citius Pharmaceuticals (CTXR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Bullfrog AI (BFRG) has outperformed Citius Pharmaceuticals (CTXR) over the past year, losing 55.6% versus a loss of 62.0%. Citius Pharmaceuticals is the larger company by market cap ($13.4 million vs $12.8 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BFRG | CTXR |
|---|---|---|
| Share price | $0.6924 | $0.4887 |
| Market cap | $12.84M | $13.42M |
| 1-day change | -2.29% | -2.47% |
| YTD return | -21.59% | -37.10% |
| 1-year return | -55.62% | -61.97% |
| 5-year return | — | -99.06% |
| EPS (TTM) | $-0.46 | $-1.75 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.96 | $2.19 |
| 52-week low | $0.425 | $0.469 |
| Distance from 52-week high | -64.67% | -77.68% |
| Analyst consensus | none | none |
| Avg. price target upside | — | +718.50% |
| Average volume | 5.34M | 527.79K |
| Shares outstanding | 18.54M | 27.45M |
| Employees | 9 | 23 |
| Sector | Healthcare | Healthcare |
| Industry | Health Information Services | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Bullfrog AI
BFRG stock →Bullfrog AI Holdings, Inc. operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States.
Healthcare · Health Information Services · 9 employees
About Citius Pharmaceuticals
CTXR stock →Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA-approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma.
Healthcare · Biotechnology · 23 employees
BFRG vs CTXR FAQ
Which is bigger, Bullfrog AI or Citius Pharmaceuticals?
Citius Pharmaceuticals (CTXR) is larger, with a market capitalization of $13.42M compared with $12.84M for Bullfrog AI (BFRG).
Which stock has performed better over the past year, BFRG or CTXR?
BFRG returned -55.62% over the past 12 months, compared with -61.97% for CTXR (price return, excluding dividends). Past performance does not predict future results.
Are Bullfrog AI and Citius Pharmaceuticals in the same industry?
Both are in the Healthcare sector, but in different industries: Health Information Services for Bullfrog AI and Biotechnology for Citius Pharmaceuticals.